Pig cell transplant trial aims to free type 1 diabetes patients from severe lows
Disease control
Recruiting now
This early-phase study tests a new treatment called OPF-310, which uses pig islet cells (the cells that make insulin) placed inside tiny capsules. The goal is to see if transplanting these cells is safe and can help adults with unstable type 1 diabetes who still have dangerous lo…
Phase: PHASE1, PHASE2 • Sponsor: Otsuka Pharmaceutical Factory, Inc. • Aim: Disease control
Last updated May 26, 2026 10:29 UTC